Literature DB >> 8957801

Long-term MR follow-up of cerebral lesions in neuro-Behçet's disease.

S Gerber1, A Biondi, D Dormont, B Wechsler, C Marsault.   

Abstract

To study the long-term evolution of cerebral lesions in neuro-Behçet's disease, MRI was carried out on 12 patients, with follow-up from 1.5 to 6 years (mean 3.5 years). On the first MRI, 66 lesions in all were found; each patient had 1-10 lesions (mean 5.5). There were 30 (46%) lesions in the brain stem, 18 (27%) in the basal ganglia region and 18 (27%) in the periventricular white matter. Of these 22 (33%) were small, 31 (47%) medium-size and 13 (20%) large lesions. On the last MRI, 60 lesions were found: each patient had 1-10 lesions (mean 5). At this time 31 lesions (52%) were in the brain stem, 13 (22%) in the basal ganglia region and 16 (26%) in the periventricular white matter. There were 41 (68%) small, 13 (22%) medium-size and 6 (10%) large lesions. About 40% of the lesions disappeared, 35% reduced in size and 25% remained unchanged. No lesion had enlarged. Of the 60 final lesions 20 (34%) were not observed on the first study. Small new lesions were found in 5 of 12 patients (42%), and were asymptomatic. Medium-size or large new lesions were found in 2 patients (17%) who had stopped steroid treatment and had a neurological relapse. Enlargement of the ventricular system or worsening of initial cerebral atrophy was observed in 9 of 12 patients. Appearance of small lesions and worsening of cerebral atrophy on long-term follow-up suggest the possibility of subclinical progression of cerebral vasculitis and should be considered in the prognosis of neuro-Behçet's disease.

Entities:  

Mesh:

Year:  1996        PMID: 8957801     DOI: 10.1007/s002340050343

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  12 in total

Review 1.  Behçet's disease: immunopathologic and therapeutic aspects.

Authors:  Robert Meador; George Ehrlich; Joan M Von Feldt
Journal:  Curr Rheumatol Rep       Date:  2002-02       Impact factor: 4.592

2.  Neuro-Behçet's disease: analysis of apparent diffusion coefficients.

Authors:  A Kunimatsu; O Abe; S Aoki; N Hayashi; T Okubo; T Masumoto; H Mori; T Yoshikawa; H Yamada; K Ohtomo
Journal:  Neuroradiology       Date:  2003-07-19       Impact factor: 2.804

3.  Magnetization transfer ratio in neuro-Behçet disease.

Authors:  Yonca Anik; Zekiye Kural; Ali Demirci; Gür Akansel; Sibel Aksu; Metin Vural
Journal:  Neuroradiology       Date:  2005-01-20       Impact factor: 2.804

4.  Neurological involvement in North Italian patients with Behçet disease.

Authors:  Andrea Lo Monaco; Renato La Corte; Luisa Caniatti; Massimo Borrelli; Francesco Trotta
Journal:  Rheumatol Int       Date:  2006-06-23       Impact factor: 2.631

5.  Brain involvement in systemic immune mediated diseases: magnetic resonance and magnetisation transfer imaging study.

Authors:  M Rovaris; B Viti; G Ciboddo; S Gerevini; R Capra; G Iannucci; G Comi; M Filippi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-02       Impact factor: 10.154

6.  MRI findings of neuro-Behcet's disease.

Authors:  Afshin Borhani Haghighi; Sirous Sarhadi; Siamak Farahangiz
Journal:  Clin Rheumatol       Date:  2010-12-18       Impact factor: 2.980

7.  Diffusion-weighted imaging in chronic Behçet patients with and without neurological findings.

Authors:  T Baysal; M Dogan; R Karlidag; H I Ozisik; O Baysal; T Bulut; K Sarac
Journal:  Neuroradiology       Date:  2005-05-26       Impact factor: 2.804

8.  Proton MRS in Behçet's disease with and without neurological findings.

Authors:  T Baysal; H I Ozisik; R Karlidag; K Sarac; O Baysal; A Dusak; E Hazneci; C Ozcan
Journal:  Neuroradiology       Date:  2003-10-31       Impact factor: 2.804

9.  Cranial MRI in Behçet's disease: 134 examinations of 98 patients.

Authors:  G Akman-Demir; S Bahar; O Coban; B Tasci; P Serdaroglu
Journal:  Neuroradiology       Date:  2003-10-14       Impact factor: 2.804

10.  MRI findings of myositis in Behçet disease.

Authors:  Gur Akansel; Yonca Akgoz; Ercument Ciftci; Arzu Arslan; Ali Demirci
Journal:  Skeletal Radiol       Date:  2004-05-01       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.